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Abstract
Background: A unique attribute of RNA molecules synthesized by RNA polymerase II is the presence of a 7-
methylguanosine (m
7G) cap structure added co-transcriptionally to the 59 end. Through its association with trans-acting
effector proteins, the m
7G cap participates in multiple aspects of RNA metabolism including localization, translation and
decay. However, at present relatively few eukaryotic proteins have been identified as factors capable of direct association
with m
7G.
Methodology/Principal Findings: Employing an unbiased proteomic approach, we identified gemin5, a component of the
survival of motor neuron (SMN) complex, as a factor capable of direct and specific interaction with the m
7G cap. Gemin5
was readily purified by cap-affinity chromatography in contrast to other SMN complex proteins. Investigating the
underlying basis for this observation, we found that purified gemin5 associates with m
7G-linked sepharose in the absence of
detectable eIF4E, and specifically crosslinks to radiolabeled cap structure after UV irradiation. Deletion analysis revealed that
an intact set of WD repeat domains located in the N-terminal half of gemin5 are required for cap-binding. Moreover, using
structural modeling and site-directed mutagenesis, we identified two proximal aromatic residues located within the WD
repeat region that significantly impact m
7G association.
Conclusions/Significance: This study rigorously identifies gemin5 as a novel cap-binding protein and describes an
unprecedented role for WD repeat domains in m
7G recognition. The findings presented here will facilitate understanding of
gemin5’s role in the metabolism of non-coding snRNAs and perhaps other RNA pol II transcripts.
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Introduction
A salient feature of RNA transcripts produced by eukaryotic
RNA polymerase II is the presence of a 7-methylguanosine (m
7G)
cap structure at the 59 terminus. In metazoans a two-component
enzyme complex engendering triphosphatase, guanylyltransferase,
and methyltransferase enzymatic activities is responsible for
modifying RNAs at the 59 end with m
7G [1]. These critical
functions are conserved in fungi and the human capping system
can replace that of Saccharomyces cerevisiae [2]. The nuclear capping
reaction serves as an important checkpoint for RNA quality
control. Multiple studies have documented that efficient pre-
mRNA splicing and polyadenylation depend upon an intact 59 cap
[3,4]. Furthermore, the cap structure is an important determinant
of mRNA stability in both the nucleus and cytoplasm [5].
Functions attributed to the cap depend upon specific trans-
acting factors that have been shown to directly bind m
7G. In the
nucleus a bipartite cap-binding complex (CBC) composed of
CBP20 and CBP80 associates with nascent pre-mRNAs to
promote splicing and export [6,7]. After gaining access to the
cytoplasm, mRNPs are remodeled to produce translation-compe-
tent particles. This process minimally involves exchange of the
CBC for eukaryotic initiation factor (eIF) 4E, the predominantly
cytoplasmic cap-binding protein responsible for directing the
initiation phase of translation [8,9]. Subsequent to translation, the
cap plays an important role in determining the end of an mRNA’s
existence. Once cytoplasmic mRNA is deadenylated, irreversible
decapping by DCP2 complexed with DCP1 results in rapid decay
of the transcript body [10]. Thus, the m
7G cap moiety participates
in every major aspect of mRNA metabolism.
In addition to mRNAs, RNA pol II mediates the synthesis of
multiple non-coding RNAs including the Sm class of small nuclear
(sn) RNAs composed of eight unique species: U1, U2, U4, U4atac,
U5, U7, U11, and U12 [11]. These snRNAs are also modified co-
transcriptionally with a 59 m
7G cap, but 39 end processing is
carried out by distinct machinery that generates mature non-
polyadenylated termini. Similar to mRNAs, newly synthesized Sm
class snRNAs are bound by CBC which, along with the adaptor
protein PHAX [12], facilitates export to the cytoplasm where
snRNAs undergo further maturation.
Eukaryotes have evolved macromolecular protein complexes of
varying complexity [13] that are responsible for cytoplasmic
assembly of snRNPs. In humans the survival of motor neuron
(SMN) complex mediates the assembly and specific deposition of
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CUUG-39) within snRNAs [14,15,16,17]. In addition to SMN
protein, the SMN complex is constituted by at least seven factors
known as gemins. The largest component of the SMN complex is
gemin5, a ,170 kDa WD repeat-containing protein that is
conserved among vertebrates [17,18]. Like other SMN complex
members, gemin5 is predominantly cytoplasmic but may also
localize to distinct sub-nuclear foci known as gems or Cajal bodies
[19]. Gemin5 has been implicated as the SMN constituent that
confers specificity to the SMN complex for Sm class snRNA
substrates [15]. This specificity depends upon recognition by
gemin5 of the ‘‘snRNP code’’ which consists of the Sm site and at
least one 39 proximal stem-loop [20]. Interestingly, a significant
fraction of cytoplasmic gemin5 appears to exist free of the SMN
complex or in a sub-complex with gemin3 and gemin4 [21].
Gemin5 also uniquely dissociates from the SMN complex under
conditions of high salinity [22]. Thus, gemin5 may be considered a
peripheral component of the SMN complex.
Subsequent to Sm core assembly, the snRNA cap is hyper-
methylated by the TGS1 methyltransferase to form 2,2,7-
trimethylguanosine (TMG) [23,24]. The import factor snurportin
directly recognizes the TMG cap [25] and, in cooperation with
SMN [26], directs nuclear import of the assembled snRNP for
final maturation steps before assembly into active spliceosomes.
Hence, as with mRNA metabolism, the 59 cap is essential for
biogenesis of snRNAs.
While it is well established that capping of RNA pol II transcripts
with m
7G is critical for their metabolism, it is not clear whether the
full complement of cellular proteins capable of binding the cap
structure has been defined. Here, we present evidence that gemin5
is capable of direct and specific interaction with m
7G in a manner
that depends upon integrity of its WD repeat domains. These
findings expand the repertoire of identified cellular m
7G cap-
binding proteins and raise the possibility that gemin5 is a novel
regulator of gene expression at the post-transcriptional level.
Results
Gemin5 is specifically purified by cap-affinity
chromatography
Efficient isolation of cap-binding complexes from cell lysates can
be achieved using m
7GTP immobilized to sepharose by covalent
linkage [27]. Cap-sepharose is widely used to investigate
interaction between eIF4E and its binding partners. Chief among
these is the scaffolding protein eIF4G, which is believed to mediate
ribosomal recruitment through interaction with eIF3 [28,29].
Exposure of cytoplasmic HeLa cell lysate to cap-sepharose
precipitates both eIF4E and eIF4G, in contrast to sepharose alone
(Figure 1A). Under the binding conditions employed here (see
experimental procedures), the abundant poly(A)-binding protein
(PABP) was not detectable in cap-resin precipitates and thus served
as an input control. Cap-affinity chromatography performed in the
Figure 1. Characterization of proteins purified by cap-affinity chromatography. (A) HeLa cytoplasmic lysate was applied to m
7G-sepharose
4B or sepharose 4B alone. Precipitates (ppt) were washed extensively and then resuspended in sample buffer. Levels of eIF4G, PABP and eIF4E in
input and supernatant (supe) samples were examined by western blot. Input samples represent 10% of total. (B) Cap-affinity chromatography was
performed in the presence of the indicated nucleotide (0.1 mM final concentration) or 0.1 mg/ml RNase A and PABP/eIF4E were detected by western
blot. (C) The same precipitate samples shown in (B) were subjected to silver stain detection. The identities of proteins determined by mass
spectrometry are indicated. (D) HeLa lysates were derived from normally growing cells (mock), cells infected with CBV3 at four hours post-infection,o r
cells acutely stressed with 0.1 mM arsenite for 30 minutes. Proteins precipitated with cap-sepharose were then analyzed by silver stain.
doi:10.1371/journal.pone.0007030.g001
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7GpppG, RNase A)
indicated robust stringency of the purification method (Figure 1B).
In particular, addition of free m
7GpppG to binding reactions
prevented eIF4E precipitation while unmethylated cap analog
(GpppG) had no effect, demonstrating strict binding specificity of
eIF4E to methylated guanosine. As with GpppG, supplementation
of reactions with ATP or treatment of lysate with RNase did not
affect eIF4E precipitation (Figure 1B).
We questioned whether proteins besides eIF4E and eIF4G were
specifically purified by cap-affinity. Analysis of precipitates shown in
figure 1B by silver stain indicated the presence of five proteins
migrating between 55 and 200 kDa whose abundances were
specifically reduced by free m
7GpppG (Figure 1C). The quantity of
a ,100 kDa protein increased substantially as a consequence of
RNase treatment, suggesting that disruption of endogenous RNPs
allows more efficient purification of this factor. These proteins were
subsequently isolated in a separate purification and analyzed by mass
spectrometry. This analysis revealed the identities of these proteins as
importin-a,CBP80,gemin4,gemin5,andeIF4G(Figure1C).CBP80
and eIF4G were expected constituents of cap-binding complexes.
Additionally, importin-a is a known interaction partner of the CBC
that mediates its nuclear import subsequent to release of the CBC’s
RNA cargo [30]. However, the presence of SMN complex
components, gemin4 and gemin5, was unexpected.
The pattern of proteins purified by cap-affinity was also
examined using lysates from cells acutely stressed with arsenite
or infected with coxsackievirus B3 (CBV3). CBV3 encodes a
protease (2A
pro) that cleaves eIF4G downstream of the eIF4E
interaction site [31]. This resulted in markedly reduced purifica-
tion of intact eIF4G and corresponding precipitation of ,100 kDa
N-terminal fragments that retain the ability to interact with eIF4E
(Figure 1D). A protein band corresponding in size to eIF4A was
also expectedly absent, since the C-terminal eIF4G fragment
produced by 2A
pro harbors eIF4A-binding sites [28,32]. Isolation
of other factors was unaffected by CBV3 infection. Short-term
arsenite exposure to induce oxidative stress did not modify the
pattern of protein pull-down, but appeared to result in elevated
CBP80 purification (Figure 1D).
Since RNase treatment significantly enhanced gemin4 recovery
by cap-affinity without affecting gemin5 pull-down, we reasoned
that gemin4 isolation was secondary to its binding partner gemin5,
and thus focused our study on the latter. In order to confirm mass
spectrometric findings, we generated cDNA clones for transient
over-expression of tagged gemin5 and eIF4E proteins (Figure 2A).
As with the corresponding endogenous factors, C-terminally
FLAG-tagged gemin5 and N-terminally myc-tagged eIF4E co-
expressed in 293T cells both specifically precipitated on cap-
sepharose but not sepharose alone (Figure 2B). We also examined
the levels of endogenous gemin5 and its binding partners gemin3
and gemin4 in cap-affinity chromatography by western blot
(Figure 2C). As expected, endogenous gemin5 was present in
precipitates, but comparatively little gemin4 was purified and
gemin3 was undetectable. This suggests that the predominant
form of gemin5 purified by cap-affinity is not bound to gemin3/4
or the SMN complex. Interestingly, we consistently observed that
only a fraction of endogenous or over-expressed gemin5 was
precipitated with cap-resin (Figures 2B and2C; compare levels in
‘‘input’’ and ‘‘supe’’ lanes), whereas eIF4E was efficiently depleted
from lysates (Figures 1A, 1B and 2B).
The WD repeat domains of gemin5 are required for
association with cap-binding complexes
We set out to identify region(s) of gemin5 that are required for
association with cap-sepharose by introducing serial deletions into
the FLAG-tagged gemin5 cDNA construct. Gemin5 is 1508 amino
acids in length and contains 13 WD repeats in its N-terminal half.
Characteristic b-propeller structures are known to be formed by 6
to 7 WD repeat domains [33], suggesting that gemin5 contains
two adjacent b-propellers (see below). Deletions of 108, 508, or
699 amino acids from the C-terminus had no effect on isolation by
cap-affinity (Figure 3A). However, truncation of 837 residues,
resulting in disruption of two intact WD repeats, completely
abrogated binding to cap-sepharose. We also performed deletion
analysis of the authentic gemin5 N-terminus. Surprisingly, a
minimal deletion of 25 amino acids abolished association with the
cap-resin (Figure 3A). Although these N-terminal residues precede
the first WD repeat, which begins at amino acid 57, structural
modeling suggests that they may participate in one of gemin5’s b-
propellers (see discussion).
We next questioned whether the minimal N-terminal deletion,
hereafter referred to as gemin5(D25), affected interaction with
Figure 2. Gemin5 isolated by cap-affinity is not bound to the
SMN complex. (A) Schematic representation of gemin5 and eIF4E
indicating locations of WD repeats, the putative coiled coil domain, and
epitope tags. (B) 293T cells were co-transfected with expression
constructs encoding FLAG-tagged gemin5 and myc-tagged eIF4E. Cell
lysate was derived 24 hours later and applied to cap-sepharose 4B or
sepharose 4B. Tagged proteins were detected with a-FLAG and a-myc
antibodies. (C) Purification of proteins by cap-affinity was performed as
in figure 1A and levels of endogenous gemin3–5 were examined in
input, supernatant and precipitate samples.
doi:10.1371/journal.pone.0007030.g002
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with plasmids expressing tagged gemin5, gemin5(D25), or vector
DNA. For additional comparison, we also expressed an N-
terminally FLAG-tagged version of human argonaute2 (Ago2), a
component of the RNA-induced silencing complex (RISC) that
has been reported to interact with gemin3 and gemin4 [34,35].
Levels of gemin3 were monitored by western blot to ensure equal
protein content in ‘‘input’’ samples (Figure 3B). Immunoprecip-
itations (IPs) using a-FLAG antibody were performed on each
lysate and precipitates were probed for the presence of gemin3 and
gemin4. Both intact gemin5 and the gemin5(D25) mutant
specifically co-immunoprecipitated gemin3 and gemin4 while
Ago2 appeared to co-purify only gemin3 (Figure 3B). Thus, the
inability of gemin5(D25) to bind cap-sepharose does not correlate
with loss of gemin3 or gemin4 interaction.
Gemin5 is an authentic cap-binding protein
We sought to identify the molecular basis underlying the
observation that gemin5 binds to m
7G cap-sepharose. One
possibility is that gemin5 binds to the prototype cap-binding
protein, eIF4E. Indeed, gemin5 has been recently suggested to be
a novel eIF4E-interaction partner (Fierro-Monti et al., 2006). To
investigate this possibility we co-expressed tagged gemin5 and
eIF4E in 293T cells and performed co-IP assays using pre-
immune, a-myc tag, and a-FLAG tag antibodies (Figure 4A and
B). Each antibody clearly and specifically precipitated its target
protein as evidenced by both western blot and silver stain.
However, there was no detectable co-IP of either protein
suggesting that eIF4E and gemin5 do not form a stable complex
in 293T cells.
Immunoprecipitated FLAG-tagged proteins can be efficiently
eluted under native conditions using FLAG peptide. We used this
approach to purify gemin5 and perform subsequent cap-affinity
chromatography in the presence of specific (m
7GpppG) or
nonspecific (GpppG) cap analog competitors (Figure 5A). Re-
markably, gemin5 was precipitated on cap-sepharose exclusively in
the presence of the nonspecific GpppG competitor. This
observation indicates that eIF4E is not responsible for tethering
gemin5 to m
7G. Silver stain analysis of precipitates from these
binding reactions revealed the presence of gemin5, but other
specific co-precipitating proteins were undetectable (Figure 5A).
This result suggested that gemin5 itself is capable of direct and
specific interaction with the m
7G cap structure.
In order to rigorously test this possibility, we employed a
strategy based on UV-induced crosslinking of proteins directly to
radiolabeled cap structure (Figure 5B). An in vitro transcribed
RNA was capped with guanylyltransferase using [a-
32P]GTP and
then incubated with immunopurified intact gemin5 or the
gemin5(D25) deletion mutant in the presence or absence of free
cap analog competitor. As an additional control, eluate from
FLAG-IP of mock-transfected cells was also used. After incuba-
tion, reactions were irradiated with UV light, treated with an
RNase cocktail, and then subjected to SDS-PAGE. In reactions
using total cytoplasmic lysate, most crosslinked proteins bound the
capped RNA nonspecifically since addition of free cap analog had
no effect on their crosslinking efficiency (Figure 5B). Importantly,
purified intact gemin5 was strongly crosslinked in a manner that
was specifically negated by the presence of free cap structure.
Moreover, the gemin5(D25) mutant was not specifically labeled by
the capped RNA. Together with data presented in figure 5A, these
results reveal that gemin5 is a protein with m
7G cap-binding
capability.
Identification of amino acid residues that mediate
gemin5 binding to m
7G
Recently, Lau et al. mapped the binding site for U4 snRNA on
gemin5 in vitro [36]. These authors found that disruption of the
WD repeat domains abrogated U4 snRNA binding whereas the
C-terminal half of gemin5 was largely dispensable. RNA-mediated
hydroxyl radical probing further revealed that U4 snRNA contacts
gemin5 near W286, located at the beginning of the fifth WD
repeat. Lau et al. performed structural modeling using the Protein
Figure 3. Mapping of determinants within gemin5 required for
association with m
7G-sepharose. (A) Multiple C-terminal trunca-
tions and a single N-terminal truncation of FLAG-tagged gemin5 were
evaluated by cap-affinity chromatography. Deletion sites within gemin5
are indicated above by amino acid number. (B) FLAG-tagged gemin5,
gemin5(D25) variant, and Ago2 expression constructs were transfected
into 293T cells along with pcDNA3 alone (M). Input samples used for co-
IP assays were analyzed by detection of gemin3 and over-expressed
FLAG-tagged proteins (left). Each lysate was subjected to IP using a-
FLAG antibody and precipitate samples were analyzed for the presence
of gemin3 and gemin4. Positions of heavy (H) and light (L) antibody
chains are indicated.
doi:10.1371/journal.pone.0007030.g003
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allowed threading of the gemin5 WD repeat domains onto the
known structure of actin-interacting protein 1 (AIP-1) [38]. This
analysis predicted W286 to be solvent exposed and located on the
surface of the first b-propeller (Figure 6A). Moreover, mutation of
this amino acid to alanine (W286A) significantly disrupted U4
snRNA-gemin5 interaction.
Since we also found that gemin5’s m
7G-binding capability maps
to the WD repeat domains, we tested whether the W286A mutant
might affect cap-binding. FLAG-tagged gemin5 and the W286A
mutant were transiently expressed in 293T cells and cap pull-down
assays were performed as in previous figures. Strikingly, mutation
of amino acid 286 abolished association with cap sepharose
(Figure 6C), indicating that this tryptophan is critical for
interaction with both m
7G and U4 snRNA.
Structural characterizations of several viral and eukaryotic cap-
binding proteins have demonstrated that association with m
7G
significantly depends upon aromatic residues that stack on either
side of the guanine base (see discussion). Since W286 is critical for
gemin5’s ability to recognize m
7G, we hypothesized that a second
aromatic residue within the vicinity of position 286 might
participate in cap-binding. Similarly to Lau et al., we utilized
PHYRE to identify predicted locations of aromatic residues that
are both solvent-exposed and located within 8 A ˚ of W286. This
distance was selected because the solved structures of eIF4E and
CBP20 reveal interplanar distances between m
7G and aromatic
side chains to be ,3.5 A ˚. Two amino acids fit these criteria, F304
and F338, with predicted distances from W286 of approximately 3
and 6 A ˚, respectively (Figure 6A). Each of these residues is located
on the exposed surface of one side of the b-propeller adjacent to
W286. In addition, all three of these amino acids are conserved in
vertebrate homologs of gemin5 (Figure 6B).
We established mutant, FLAG-tagged gemin5 expression
constructs F304A and F338A and tested their cap-binding activity
side by side with wild-type gemin5 and W286A (Figure 6C).
Mutation of F304 did not affect purification by cap-affinity
chromatography. In contrast, the F338A variant exhibited
significantly reduced association with cap-sepharose compared to
either wild-type gemin5 or the F304A construct but, unlike
W286A, was still detectable in cap precipitates. These findings
indicate that F338 and W286 are important for cap recognition by
gemin5 and suggest these residues may participate in stacking
interactions with m
7G as in structurally-characterized cap-binding
proteins. On the other hand, we cannot rule out the possibility that
W286A and/or F338A mutations affect global structure of gemin5
in a manner that reduces affinity for the m
7G cap.
Figure 4. Gemin5 fails to detectably interact with eIF4E in co-IP experiments. 293T cells were co-transfected with gemin5 and eIF4E
expression constructs as in figure 2 and cytoplasmic lysate was used for IP using the indicated murine antibodies (IgG, a-myc, and a-FLAG). (A) Input
and supernatant samples assayed for levels of over-expressed proteins. (B) Each IP was analyzed by western blot with a-eIF4E (left) and a-FLAG
(middle) rabbit antibodies, and by silver stain (right). Blots were intentionally over-exposed to assess possible co-IP. Asterisks indicate mouse light
antibody chain used in IP reactions that cross reacts with rabbit secondary antibody.
doi:10.1371/journal.pone.0007030.g004
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snRNA
We next examined the effects of gemin5 mutations on
association with U1 snRNA, a well-known substrate of the SMN
complex. RNA immunoprecipitation (RIP) and quantitative RT-
PCR (RT-qPCR) methods were employed to measure levels of
endogenous U1 snRNA co-precipitating with FLAG-tagged
gemin5 over-expressed in 293T cells (Figure 7). The same analysis
was applied simultaneously to gemin5(D25) and the W286A/
F338A amino acid substitution mutants that display significantly
reduced binding to m
7G. Compared to negative control RIP with
species-matched IgG, gemin5 RIP enriched U1 snRNA by
approximately 35-fold (Figure 7B). This was specific for U1
snRNA as measurements of the Lsm class U6 snRNA, a non-
substrate of the SMN complex, were equivalent in gemin5 and
negative control RNA immunoprecipitates. Interestingly, each
mutant version of gemin5 specifically enriched U1 snRNA
compared to negative controls, perhaps reflecting a degree of
indirect association of gemin5 with U1 snRNA through other
SMN complex components. Nevertheless, each mutant consis-
tently co-precipitated U1 snRNA to a lesser extent than intact,
wild-type gemin5 (Figure 7B) despite somewhat less abundant
expression and immunoprecipitation of the latter (Figure 7A).
Taken together with data presented in figure 6, these observations
along with those made by Lau et al. suggest that determinants of
binding to m
7G and U1 snRNA are closely associated in the WD
repeat domains of gemin5.
Discussion
Cellular proteins capable of recognizing the m
7G cap-structure
added co-transcriptionally to all RNA pol II transcripts execute
critical functions in mRNA and snRNA metabolism. Here, we
identify gemin5, a peripheral component of the SMN complex, as
a novel m
7G cap-binding protein. Gemin5 was specifically purified
by cap-affinity chromatography (Figures 1 and 2), but did not
detectably interact in co-IP assays with the prototypic cap-binding
protein, eIF4E (Figure 4). Crucially, immunopurified gemin5
bound cap-sepharose in the absence of other proteins, and
specifically crosslinked to radiolabeled cap-structure after UV
irradiation (Figure 5). The latter being the most stringent criterion
for evaluating putative cap-binding activity [6,8,39]. Thus, gemin5
may be considered a new member of the m
7G cap-binding class of
proteins.
Figure 5. Gemin5 binds directly to the m
7G cap structure. (A) FLAG-tagged gemin5 was immunoprecipitated and released from the resin with
FLAG peptide. Eluted protein was subsequently applied to cap-sepharose in the presence of free m
7GpppG or GpppG competitors. Precipitation of
FLAG-gemin5 was monitored by western blot and silver stain analysis. (B) A representation of the m
7G cap structure is shown with position of
radiolabeled a-phosphate indicated by an asterisk. A short RNA transcript was synthesized and then modified with an m
7G cap using [a-
32P]-GTP and
guanylyltransferase (see experimental procedures for details). Purified capped RNA was incubated in the presence or absence 0.1 mM free cap analog
with 1) 293T cytoplasmic lysate, 2) eluate from a-FLAG IP of lysate from pcDNA3-transfected cells (mock IP), or 3) FLAG-tagged gemin5 or
gemin5(D25) immunopurified as in (A). Binding reactions were irradiated with UV light, incubated with RNase cocktail, and then analyzed by SDS-
PAGE followed by autoradiography as indicated.
doi:10.1371/journal.pone.0007030.g005
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have revealed a similar structural motif involved in cap recognition
shared among multiple identified cellular and viral cap-binding
proteins including eIF4E [40], CBP20 [41], 4E-HP [42], vaccinia
virus VP39 [43], and influenza virus PB2 [44]. Each of these
proteins bind the cap structure via conserved aromatic side chains
that stack on either side of m
7G, forming a cap ‘‘sandwich’’. We
investigated the molecular determinants responsible for gemin5
interaction withm
7G.Deletionanalysisrevealedthatintegrityofthe
13 WD repeats present in the N-terminal half of gemin5 are
important for cap-binding, indicating an unprecedented structural
association between the propeller-like platforms known to be
formedbytandemly-arrayedWDrepeatsandthecap-binding motif
(Figure 3). Moreover, structural modeling using the PHYRE
algorithm combined with site-directed mutagenesis putatively
identified unique aromatic amino acids (W286 and F338; located
in the 5
th and 6
th WD repeats, respectively) that may directly
mediate cap interaction similar to previously characterized cap-
binding proteins (Figure 6). However, the possibility that gemin5
associates with the cap structure via an alternative mode cannot be
ruled out. For example, poly(A)-specific ribonuclease (PARN) has
been demonstrated to bind m
7G via a single one-sided stacking
interaction involving tryptophan [45,46,47]. The PHYRE analysis
also suggested an integral role for involvement of the N-terminal 25
residues in the structure of the first b-propeller. In particular, this
region is predicted to compose the first b-strand of the N-terminal
WD repeat (Figure 6A), and deletion of these amino acids may have
broaddestabilizingeffectsthat preclude specificrecognitionofm
7G.
In contrast to eIF4E, cap-affinity chromatography consistently
failed to significantly deplete gemin5 from cell lysates (Figures 1
and 2). One possible explanation for this finding is that the steady-
state affinity of gemin5 for the cap is significantly lower compared
to that of eIF4E. On the other hand, gemin5’s cap-binding
capability may be negatively regulated by interaction with its
partner protein(s). Notably, gemin5 purified on cap-sepharose
minimally co-precipitates gemin4 without RNase treatment and
fails to pull down gemin3, although direct IP of gemin5 efficiently
co-purifies both proteins [21](our unpublished data). These
observations indicate that gemin5 purified by cap-affinity is largely
a free subunit not bound to gemin3/4 or the entire SMN complex.
Gemin5 has been implicated as the factor responsible for
identifying known substrates of the SMN complex, the Sm-class
Figure 6. Identification of amino acid residues that affect m
7G recognition by gemin5. (A) PHYRE analysis was used to model the gemin5
WD repeat domains onto the structure of actin-interacting protein 1 (AIP-1; see Materials and Methods). The backbone of the AIP-1 structure,
consisting of two b-propellers, is shown with indicated locations of amino acids highlighted in yellow. A 90u x-axis rotation of the left structure is
shown at right. Arrows indicate positions of W286 (red), F304 (yellow), F338 (blue) and the N-terminal 25 amino acids of AIP-1 (green). Note that the
N-terminus of AIP-1 forms a b-sheet in the last WD repeat domain of the second b-propeller before looping into the first b-propeller to form another
b-sheet. PHYRE analysis predicts only the second b-sheet in gemin5. AIP-1 structures were visualized using Cn3D [59]. (B) Alignments of gemin5
sequences from selected vertebrate species is shown. Bold letters in the human sequence indicate uniform conservation and positions of residues
286, 304 and 338 are indicated. (C) Cap-binding assays were performed with wild-type gemin5-FLAG and variants as in previous figures. Input (i),
supernatant (s), and precipitate (ppt) samples are indicated.
doi:10.1371/journal.pone.0007030.g006
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code’’, generically consisting of the Sm site and a 39 proximal
stem-loop, is necessary and sufficient for recognition of Sm class
snRNAs by gemin5 [36,48]. Thus, although Sm-class snRNAs are
capped during transcription by RNA pol II, the m
7G moiety is
apparently dispensable for specific binding to gemin5, at least in
vitro. Interestingly, W286 is required for maximum gemin5
binding to both m
7G and U1/U4 snRNAs (Figures 6 and 7) [36],
indicating that the recognition site(s) for these ligands at least
partially overlap. It will be of interest to determine whether cap-
and snRNA-binding to gemin5 are mutually exclusive.
Gemin5 has been reported to accumulate in stress granules [21],
discrete cytoplasmic foci that contain specific initiation factors,
RNA-binding proteins, small (40S) ribosomal subunits and
translationally-silent mRNAs [49]. Since gemin5 is also capable
of cap-binding, it may conceivably participate in RNP complexes
containing mRNAs. Hypothetical gemin5 mRNPs would likely
exist in translationally-silent, sub-polysomal complexes through
preclusion of eIF4E association with the cap. Indeed, the vast
majority of gemin5, whether as free protein or bound to the SMN
complex, is present in translationally inactive fractions of polysome
gradients [21](our unpublished data). Notably, gemin5 has been
recently reported to be capable of inhibiting both cap- and viral
internal ribosome entry site (IRES)-dependent translation initia-
tion [50]. However, whether gemin5 actually binds and regulates
translation of endogenous cellular or viral mRNAs in vivo is still an
open question deserving further inquiry.
Translational repression mediated by microRNAs (miRNAs)
represents one scenario where mRNAs may be transiently
remodeled into silenced particles prior to decay or resumption of
active translation. Though mechanisms of miRNA function
remain obscure [51,52], multiple studies have implicated the
m
7G cap structure as a cis-acting element that confers suscepti-
bility to repression by miRNAs [53,54,55,56]. Indeed, the
miRNA-associated protein Ago2 was reported to repress mRNA
translation through direct interaction with the 59 cap [57],
although this claim has been recently questioned [58]. Given its
association with gemin3 and gemin4 [21], both of which appear to
participate in complexes with Ago2 [34,35], and its m
7G-binding
capability reported here, a possible role for gemin5 in miRNA-
mediated silencing deserves examination.
Materials and Methods
Cap-affinity chromatography and western blotting
HeLa and 293T cell lysates were prepared using polysome lysis
buffer (PLB) as described [59]. Cap-binding reactions were
performed at 4uC with one mg protein and 15 mlm
7GTP-
sepharose or sepharose-4B (GE Healthcare) in NT2 buffer
[50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM MgCl2,
0.05% NP40] for one hour. Binding reactions were performed
in the presence or absence or 0.1 mM cap analogs (GpppG or
m
7GpppG). Sepharose beads were washed 3 times with 1 ml NT2
buffer and then resuspended in sample buffer for SDS-PAGE.
Antibodies to eIF4E (Abcam), PABP [60], gemin5 (BD Bioscienc-
es), gemin4 (Santa Cruz), gemin3 (Abcam), FLAG-tag (Sigma),
and myc-tag (Sigma) were used for western blotting. Antibody to
eIF4G was produced at the Duke University antibody production
facility. For preparative purification of cap-binding complexes the
reaction described above was scaled up 4-fold and proteins
detected by coomassie staining were analyzed at the University of
Massachusetts Medical School Proteomics Facility (Worcester,
MA).
Immunoprecipitations and UV crosslinking
Buffers used for lysate preparation (PLB) and binding reactions
(NT2) were identical to those used in cap-binding assays. IP
reactions were incubated one hour and contained 40 ml protein G-
sepharose (GE Health Sciences) bound to 10 mg antibody and
2 mg protein lysate. Washed immunoprecipitates were resus-
pended in either sample buffer for SDS-PAGE, Trizol reagent
(Invitrogen) for RNA extraction, or NT2 buffer with 0.1 mg/ml
FLAG peptide (Sigma) for elution of FLAG-tagged proteins. For
UV-crosslinking experiments, RNA containing the Xenopus
elongation factor 1a gene was in vitro transcribed (Megascript,
Ambion) and capped using vaccinia virus guanylyltransferase and
[a-
32P]-GTP according to the manufacturer’s protocol (Ambion).
Immunoprecipitated FLAG-tagged gemin5 and gemin5(D25) were
concentrated using Microcon filter devices (Millipore). Cross-
linking reactions (20 ml) contained 60 ng labeled RNA, 40 ng
immunopurified protein or 120 mg cytoplasmic lysate, 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, and 1 mM MgCl2. Reactions
were incubated 10 minutes at RT and then irradiated 20 minutes
on ice with a UV Stratalinker (Stratagene). After crosslinking,
reactions were treated with 1 ml RNase cocktail (Ambion) for 10
minutes at RT and then subjected to SDS-PAGE.
Cloning of cDNA constructs and transfections
Gemin5 cDNA clone was obtained from ATCC (RefSeq:
NM_015465) and the coding region was inserted into pcDNA 3.1
(Invitrogen) using KpnI and NotI. This clone was modified with a
Figure 7. Gemin5 mutations that affect m
7G interaction reduce
association with U1 snRNA. (A) Gemin5-FLAG and the indicated
variants were transiently expressed in 293T cells and then immunopre-
cipitated with a-FLAG antibody or negative control mouse IgG. A 10%
fraction of IP samples along with input samples were subjected to a-
FLAG western blot. The asterisk indicates a cross-reactive band that
serves as a loading control. The remaining IPs were used for RNA
extraction. (B) RT-qPCR was performed on extracted RNAs for measure-
ments of U1 and U6 snRNA levels in positive and negative IP samples for
each gemin5 variant. Error bars indicate values for standard deviation.
doi:10.1371/journal.pone.0007030.g007
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constructs were derived in a similar fashion. Point mutations were
generated by overlap fusion PCR [61] and standard cloning
techniques. The eIF4E clone was established by RT-PCR
amplification of HeLa total RNA and the PCR fragment was
inserted into pcDNA 3.1 containing a myc-tag [62]. N-terminally
FLAG-tagged Ago2 in pcDNA 3.1 was derived by standard
methods from a cDNA clone (ATCC; RefSeq:NM_012154). All
clones were sequenced to ensure correctness. Transfection of
expression plasmids for IP or cap-pull down experiments was
performed with 293T cells grown on 10 cm dishes. Cells were
transfected with 10 mg DNA and 40 ml lipofectamine 2000
(Invitrogen). Twenty-four hours later cells were harvested and
lysed as described above.
Structural modeling
The PHYRE program [37] was used to model the WD repeat
domain structure of gemin5 as described previously [36]. PHYRE
analysis predicted actin-interacting protein 1 (AIP-1; Q11176) as a
factor with significant structural homology to the WD repeat
region of gemin5. The solved structure of AIP-1 [38] was used to
model positions of gemin5 amino acids W286, F304 and F338 as
well as the N-terminus. Structures were visualized using Cn3D
[63].
Quantitative RT-PCR (RT-qPCR)
One step RT-qPCR reactions were performed on co-precipi-
tating RNA from IP reactions using SYBR green reaction mix
(Roche) and the following primers specific for target RNAs: (U1
snRNA-forward)59-GGGAGATACCATGATCACGAAGGT-39;
(U1 snRNA-reverse) 59-ATGCAGTCGAGTTTCCCACA-39;
(U6 snRNA-forward) 59-CTCGCTTCGGCAGCACATATAC-
TA-39; (U6 snRNA-reverse) 59-ACGAATTTGCGTGTCAT-
CCTTGCG-39. Real-time PCR was conducted using a Roche
Light Cycler. Reactions were performed in triplicate on at least
two separate experiments for each gemin5 variant and the DDCt
method was used to calculate fold changes in positive versus
negative IPs. A representative experiment is shown in figure 7.
Statistical analysis was performed as described [64].
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